New research suggests popular weight loss drugs like Ozempic and Wegovy may affect more than just fat, raising questions about muscle strength and organ size after significant weight loss.

University of Utah scientists studied semaglutide, the active ingredient in weight loss medications, in mice.

In the study, published in the journal Cell Metabolism, researchers revealed "unexpected effects," highlighting that lean mass, or body weight that isn't fat, dropped about 10 percent. Most of the loss came from non-muscle tissues, particularly........

© The Hill